or Try an Advanced Search...

    Advanced Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    ACHL C Achilles Therapeutics plc 0.00
    BYSI F BeyondSpring, Inc. -6.55
    CRIS F Curis, Inc. 3.57
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Antineoplastic Drugs Cancer Treatment Clinical Medicine Small Cell Lung Cancer Solid Tumors Biopharmaceutical Bladder Cancer Breakthrough Therapy Breast Cancer Buparlisib Cancer Cell Cancer Immunotherapy Cancer Therapeutics Cancer Therapies Carcinoma Chemotherapy Docetaxel Drug Discovery Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Advanced Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    IWC A iShares Microcap ETF 0.01
    View all Advanced Non Small Cell Lung Cancer ETFs...
    Compare ETFs

        Advanced Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Nov 5 CRIS Curis up 4% on emavusertib data in myelodysplastic syndrome
        Nov 2 CRIS Curis price target lowered to $20 from $26 at H.C. Wainwright
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Antineoplastic Drugs Cancer Treatment Clinical Medicine Small Cell Lung Cancer Solid Tumors Biopharmaceutical Bladder Cancer Breakthrough Therapy Breast Cancer Buparlisib Cancer Cell Cancer Immunotherapy Cancer Therapeutics Cancer Therapies Carcinoma Chemotherapy Docetaxel Drug Discovery Drugs
        Advanced Non Small Cell Lung Cancer

        Advanced non-small cell lung cancer (NSCLC) is a type of lung cancer that has spread beyond the lungs to other parts of the body. It is the most common type of lung cancer, accounting for about 85% of all cases. Symptoms of advanced NSCLC may include shortness of breath, chest pain, fatigue, and weight loss. Treatment options for advanced NSCLC may include chemotherapy, radiation therapy, targeted therapy, and immunotherapy.

        Browse All Tags